Sasco Capital Inc. CT Reduces Holdings in Stericycle, Inc. (NASDAQ:SRCL)

Sasco Capital Inc. CT trimmed its position in shares of Stericycle, Inc. (NASDAQ:SRCL) by 14.2% in the 3rd quarter, Holdings Channel reports. The firm owned 301,747 shares of the business services provider’s stock after selling 50,010 shares during the period. Stericycle accounts for approximately 2.8% of Sasco Capital Inc. CT’s portfolio, making the stock its 20th largest position. Sasco Capital Inc. CT’s holdings in Stericycle were worth $18,407,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Quest Partners LLC boosted its stake in Stericycle by 133.9% during the third quarter. Quest Partners LLC now owns 2,199 shares of the business services provider’s stock worth $134,000 after buying an additional 1,259 shares during the last quarter. Natixis Advisors LLC lifted its stake in shares of Stericycle by 12.1% in the 3rd quarter. Natixis Advisors LLC now owns 14,489 shares of the business services provider’s stock valued at $884,000 after purchasing an additional 1,565 shares during the last quarter. OneDigital Investment Advisors LLC lifted its stake in shares of Stericycle by 1.3% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 13,723 shares of the business services provider’s stock valued at $837,000 after purchasing an additional 171 shares during the last quarter. ING Groep NV lifted its stake in shares of Stericycle by 537.6% in the 3rd quarter. ING Groep NV now owns 483,300 shares of the business services provider’s stock valued at $29,481,000 after purchasing an additional 407,500 shares during the last quarter. Finally, Versor Investments LP lifted its stake in shares of Stericycle by 156.0% in the 3rd quarter. Versor Investments LP now owns 143,124 shares of the business services provider’s stock valued at $8,731,000 after purchasing an additional 87,214 shares during the last quarter. 98.82% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, StockNews.com started coverage on Stericycle in a research note on Tuesday, November 12th. They issued a “hold” rating on the stock. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Stericycle currently has a consensus rating of “Hold” and an average target price of $74.00.

Stericycle Price Performance

Shares of NASDAQ SRCL opened at $61.98 on Tuesday. The stock’s 50-day moving average is $61.37 and its two-hundred day moving average is $57.95. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.20 and a quick ratio of 1.13. Stericycle, Inc. has a 1-year low of $37.78 and a 1-year high of $61.99. The company has a market cap of $5.75 billion, a price-to-earnings ratio of 163.11, a price-to-earnings-growth ratio of 3.38 and a beta of 1.10.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.